Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

NCT01464762 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: TMC207

Sponsor

Janssen Infectious Diseases BVBA